MoonLake Immunotherapeutics MLTX Accrued Expenses
Accrued Expenses at other companies
Other financials
Where this comes from
Reported directly by MoonLake Immunotherapeutics in its filing.
Tagged under the XBRL concept us-gaap:EmployeeRelatedLiabilitiesCurrent.
The official record: MoonLake Immunotherapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about MoonLake Immunotherapeutics's accrued expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is MoonLake Immunotherapeutics's accrued expenses?
- MoonLake Immunotherapeutics (MLTX) reported accrued expenses of $2.2M in Q1 2026.
- How has MoonLake Immunotherapeutics's accrued expenses changed year-over-year?
- MoonLake Immunotherapeutics's accrued expenses decreased by 13.5% year-over-year, from $2.54M to $2.2M.
- What is the long-term trend for MoonLake Immunotherapeutics's accrued expenses?
- Over 5 years (2020 to 2025), MoonLake Immunotherapeutics's accrued expenses has grown at a 103.2% compound annual growth rate (CAGR), from $67.12K to $2.32M.
- What does accrued expenses mean?
- Expenses incurred but not yet paid or invoiced — interest accruals, tax accruals, warranty reserves, and other timing differences.